Home
Dashboard
Curated content
Startups & Scaleups
Corporates
Investors
Funding rounds
Exits
Accelerators
More organizations
Companies
IGXBio
Team
Team
Save
IGXBio
Biotechnology company developing advanced dna immunotherapies for hiv infection.
Launch date
2001
Employees
2-10 people
Market cap
-
Enterprise valuation
$2—3m
(Dealroom.co estimates Dec 2010.)
Lenexa Kansas (HQ)
http://igxbio.com
B2B
health
biotechnology
hard tech
biotechnology
biotech and pharma
genetics
dna
genome engineering
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Authorizing premium user...
